Synergistic effect of serotonin 1A and serotonin 1B/D receptor agonists in the treatment of L-DOPA-induced dyskinesia in 6-hydroxydopamine-lesioned rats

Experimental Neurology(2022)

引用 2|浏览3
暂无评分
摘要
•Buspirone and zolmitriptan synergistically reduce L-DOPA-induced dyskinesia in a rodent Parkinson's disease model.•The buspirone and zolmitriptan combination is safe and does not lead to tolerance development.•The anti-dyskinetic effect of buspirone and zolmitriptan combined is superior to amantadine.
更多
查看译文
关键词
Dyskinesia,Parkinson's,Buspirone,Zolmitriptan,5-HTR agonist
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要